Bicycle Therapeutics Plc (BCYC)
4.55
+0.10
(+2.25%)
USD |
NASDAQ |
May 22, 16:00
4.55
0.00 (0.00%)
Pre-Market: 20:00
Bicycle Therapeutics Free Cash Flow : -231.83M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.310M |
| Mereo BioPharma Group Plc | -27.29M |
| NuCana Plc | -9.929M |
| Autolus Therapeutics Plc | -295.51M |
| Cellectis SA | -41.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -65.81M |
| Cash from Investing (Quarterly) | -0.7118M |
| Cash from Financing (Quarterly) | -0.0539M |
| Free Cash Flow Per Share (Quarterly) | -0.9547 |
| Free Cash Flow to Equity (Quarterly) | -64.95M |
| Free Cash Flow to Firm (Quarterly) | -66.48M |
| Free Cash Flow Yield | -73.42% |